Raspa M, Bishop E, Candrilli S, Mitra D, Sacco P, Petrillo J, Bailey D. US caregiver burden in Fragile X syndrome as a function of a health-state utility index. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A625.
Korsnes JS, Goodwin BB, Candrilli SD. The association between adherence to antiretroviral therapy and economic outcomes among commercially insured and medicaid hiv patients in the United States. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A348-9.
Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R. Factors associated with pain persistence in patient with depression during a 3-month follow-up period. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Amsterdam, The Netherlands. [abstract] Value Health. 2013 Nov; 16(7):A544.
Ara R, Basarir H, Keetharuth A, Weatherly H, Barbieri M, Sculpher MJ. Economic evidence of surgical procedures in cancer: a systematic literature review. Poster presented at the 2013 ISPOR 16th Annual European Congress; October 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A411. doi: 10.1017/S0266462314000531
Rouse M, McKenna S, Twiss J, Graham JE, Wilburn J. Quality of life outcomes in multiple sclerosis: a review of the literature. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A626. doi: 10.1016/j.jval.2013.08.1843
Graham JE, McKenna S, Wilburn J, Twiss J. Assessing quality of life in adult growth hormone deficiency: further development of the QoL-AGHDA. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A446-7. doi: 10.1016/j.jval.2013.08.710
Mladsi DM, Ronquest NA, Tannus G, Fonseca M, Saag K. Estimated cost effectiveness of lower-dose submicron diclofenac compared with traditional diclofenac in Brazil. Poster presented at the 2013 ISPOR 4th Latin America Conference; September 2013. Buenos Aires, Argentina. [abstract] Value Health. 2013 Sep; 16(7):PA717-8. doi: 10.1016/j.jval.2013.08.2226
Brogan A, Talbird S, Thompson J, Kim Y, Olson J, Peterson J, Piontkowsky D, Pietrandoni G. Budget impact of the introduction of elvitegravir/cobicistat/emtricitabine/tenofovir, the first integrase inhibitor-based single-tablet antiretroviral regimen for HIV treatment, to US third-party payers. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2, 2013. Dublin, Ireland. [abstract] Value Health. 2013 Aug; 16(7):A343-4.
Mines D, Nickel KB, Wallace AE, Warren DK, Olsen MA. Using claims data for surgical site infection surveillance after herniorrhaphy. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):a79.
Candrilli S, Karve S. Recent trends in type-2 diabetes mellitus–related inpatient care among pediatric patients in the United States. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 1, 2013. [abstract] Value Health. 2013 May; 16(3):A162.
Copley-Merriman K, Olanrewaju B, Hogue S. The temporal relationship between NSAIDS and risk of gastrointestinal, cardiovascular, and renal events: a systematic review. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2, 2013. [abstract] Value Health. 2013 May; 16(3):A110.
Davis KL, Fitzgerald TP, Meyers J, Kulkarni A, Svarvar P, Hewitt DJ. Economic burden of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A103-4.
Davis KL, Fitzgerald T, Meyers J, Kulkarni A, Svarvar P, Hewitt D. Incidence of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 15, 2013. [abstract] Value Health. 2013 May; 16(3):A100.
Davis KL, Fitzgerald T, Kulkarni A, Meyers J, Svarvar P, Hewitt D. Comparative risk of adverse treatment effects in parkinson's disease: evidence from a large employer population. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 15, 2013. [abstract] Value Health. 2013 May; 16(3):A100.
Copley-Merriman C, Olanrewaju B, Hogue S. Systematic literature review of the temporal relationship between nsaid use and gastrointestinal, cardiovascular, or renal events. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A110.
DiBenedetti D, Coles T, Sharma T. Recruiting patients with a rare blood disorder and their caregivers through social media. Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 23, 2013. [abstract] Value Health. 2013 May; 16(3):A51.
DiBenedetti D, Coles T, Ling CS, Sharma T, Pericleous L. Web-based study of patients and caregivers in the United States and Canada: perspectives on improvements in stability of factor viii products for hemophilia a. Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 30, 2013. [abstract] Value Health. 2013 May; 16(3):A121.
Brennan VK, Colosia AD, Copley-Merriman C, Hass B, Palencia R. Systematic literature review of utilities relating to patients with type-2 diabetes mellitus experiencing a stroke or myocardial infarction. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A168. doi: 10.1016/j.jval.2013.03.841
Brennan VK, Colosia AD, Copley-Merriman C, Hass B, Palencia R. Systematic literature review of costs related to patients with type 2 diabetes mellitus experiencing a stroke or myocardial infarction. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 7, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A162. doi: 10.1016/j.jval.2013.03.811
Odom D, Brogan AJ, Talbird SE, Schenkel B. A network meta-analysis of randomized, controlled trials of ustekinumab and adalimumab for moderate-to-severe psoriasis. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. [abstract] Value Health. 2013 May; 16(3):A112. doi: 10.1016/j.jval.2013.03.532
Xe Y, Bays H, Schwab PE, Louder A. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 18, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A295. doi: 10.1016/j.jval.2013.03.1529
Mordin M, Hogue S, Barrows S, van Amerongen D. Safe and effective versus reasonable and necessary: is the deck stacked against medical devices? Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 30, 2013. [abstract] Value Health. 2013 May; 16(3):246.
Mordin M, Copley-Merriman C, Mauskopf J, Sweeney C, Bhattacharyya S, Farup C, Beach W, Higgins L, McIntyre L. Surgical innovation: do we need a more balanced framework for evidence? Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 3, 2013. [abstract] Value Health. 2013 May; 16(3):A247.
Barrett A, DiBenedetti D, Phatak H, lloeje U. Structured review of patient-reported outcome instruments for assessing atrial fibrillation. Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 23, 2013. [abstract] Value Health. 2013 May; 16(3):A293.
Herring WL, Mladsi D, Mauskopf J. Patient-level simulation modeling for economic evaluations: opportunities and challenges in a practical setting. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 1, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A28-9.
Herring WL, Mladsi DM, Miles L, Ronquest N. A novel approach to ranking parameter uncertainty in one-way sensitivity analysis: what tornado diagrams are missing. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 1, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A20.
Ronquest N, Mladsi D, Hopley C, Edgell E. The economic value of an innovative knee implant system for total knee arthroplasty. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 6, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A225.
Yuan Z, Levitan B, Burton P, Poulos C, Hauber AB, Berlin J. Relative importance of benefits and risks associated with antithrombotic therapies of acute coronary syndrome: patient and physician perspectives. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A292-3.
Chopra I, Kamal KM, Candrilli SD, Kanyongo G. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A293-4.
Fortuny J, Leteneux-Pantias C, Xu X, Plana E. Prevalence and incidence of pathologic myopia and retinal neovascularization in a US managed care database. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, United States. [abstract] Value Health. 2013 May; 16(3):A176.
Davis KL, Meyers J, Zhao Z, McCollam P, Murakami M. High-risk vascular disease in Japan: evidence on incidence and prevalence, patient characteristics, and treatment rates from a large Japanese claims database. Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 23, 2013. [abstract] Value Health. 2013 Apr; 16(3):A277.
Stull DE, Houghton K. Identifying differential responders and their characteristics in clinical trials: innovative methods for analyzing longitudinal data. Value Health. 2013 Jan 1;16(1):164-76.
Redekop WK, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health. 2013;16(Suppl 6):S4-9. doi: 10.1016/j.jval.2013.06.005.
Candrilli S, Davis KL, Yen L. Characteristics of diverticulitis-related emergency department visits in the United States. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A328.
Mitra D, Whiteley J, Iyer S, Candrilli S, Kaye JA. Treatment and response patterns in chronic myeloid leukemia: evidence from a retrospective study in Canada, Australia, and South Korea. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A413. doi: 10.1016/j.jval.2012.08.1217
Davis KL, Mitra D, Yen L. Clinical characteristics, treatment patterns, and resource utilization in a real-world European population with diverticulitis. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A535-6.
Twiss J, Ganderton L, Jenkins S, Ben-L'amri M, Gain K, Fowler R, Gabbay E, McKenna S. Comparison of the psychometric properties of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) and the SF-36 in patients with pulmonary hypertension. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A378-9.
Mauskopf J, Beach W, McIntyre L, Bhattacharyya S, Higgins L, Mordin M, Copley-Merriman K. Evidence-based medicine: a case study of its application to innovative surgical procedures in the United Kingdom. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 7, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A408.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and/or obesity in patients with type 2 diabetes mellitus throughout the world: a systematic literature review. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A496.
Colosia AD, Palencia R, Khan S. Prevalence of hypertension and/or obesity in patients with type 2 diabetes mellitus in Asia: a systematic literature review. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A661.
Helbert M, Pang F, Alvarez-Reyes M, Pearson IV, Wolowacz S, Diwakar L. A cost-effectiveness comparison of icatibant and c1-esterase inhibitor concentrate for the symptomatic treatment of acute attacks of types i and ii hereditary angioedema in the UK setting. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 13, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A513.
Gnanasakthy A, Doward L, Clark M, Mordin M, DeMuro C. Concordance of pro labeling claims between the FDA and EMA. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A321.
Hicks K, Earnshaw S, McDade C, Shaw JW, Cifaldi MA. Benefit-risk analysis of adalimumab and alternative treatments for moderate to severe rheumatoid arthritis. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 13, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A439-40.
Mersey J, Wei W, Meyers J, Wang CC, Dalal MR, Bromberger LA, Levin P. Real-world treatment patterns and outcomes when initiating once-daily injectable pen therapy with insulin glargine or liraglutide - an electronic medical records study. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A494. doi: 10.1016/j.jval.2012.08.1648
Mordin M, Clark M, Doward L, Willian M. Pediatric patient-reported outcomes assessment: a case study in epidermolysis bullosa. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A480-1.
Pearson IV, Wolowacz SE, Irving AH, Brockbank JA, Chubb B, Gundgaard J, Briggs A, Davies M. A systematic review of recent data describing the risk of complications in type 1 diabetes mellitus patients. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A496-7.
Forsyth B, Fehnel SE, Danchenko N, Franois C, Brevig T. Assessing impacts of major depressive disorder (MDD) on cognitive function. Value Health. 2012 Nov 1;15(7):A341.
Badia X, Forsythe A, Nelson LM, Coles TM, McLeod LD, Webb SM. Improvements in health-related quality of life in acromegaly with pasireotide LAR and octreotide LAR: results from a large, randomized, double-blind phase III trial. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A505.
Pellock JM, Carman WJ, Thyagarajan (Hoffman) V, Daniels T, Morris DL, D'Cruz O. Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review. Neurology. 2012 Oct 2;79(14):1482-9. doi: 10.1212/WNL.0b013e31826d5ec0
Lewis S, Price M, Mordin M, Dwyer K, Heekin R, Yates P, O'Brien S, Beverland D. Assessing performance following primary total knee arthroplasty: development of the patient's knee implant performance (PKIP) measure. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. [abstract] Value Health. 2012 Jun 1; 15(4):A70.